These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 13432263)
1. [Treatment of circulatory disturbances by nucleoside extracts and invert sugar]. CIDADE MA; FRANKEL PE Rev Bras Med; 1956 Oct; 13(10):751-9. PubMed ID: 13432263 [No Abstract] [Full Text] [Related]
2. [Ambulant treatment of peripheral circulation disorders of the legs with phosaden]. HARTH V Med Klin; 1958 Jul; 53(30):1309-11. PubMed ID: 13565343 [No Abstract] [Full Text] [Related]
3. [New aspects of treatment of peripheral and central circulatory disorders]. REDLIN HH Med Klin; 1953 Dec; 48(51):1897-8. PubMed ID: 13132381 [No Abstract] [Full Text] [Related]
4. Tissue engineering therapy for cardiovascular diseases. Tiwari A; Hamilton G; Seifalian AM Circ Res; 2003 Jul; 93(2):e1. PubMed ID: 12881476 [No Abstract] [Full Text] [Related]
6. Vascular disease: medical therapy, surgery and interventional technologies. Korr KS Med Health R I; 2008 Oct; 91(10):300. PubMed ID: 19044103 [No Abstract] [Full Text] [Related]
7. Office management of peripheral circulatory disturbances. REDISCH W J Med Soc N J; 1961 May; 58():214-7. PubMed ID: 13740224 [No Abstract] [Full Text] [Related]
8. [Results of treatment with adenosine-5-monophosphoric acid in various vascular disorders]. GUGEL-FRANK M Med Klin; 1957 Nov; 52(46):2004-5. PubMed ID: 13493008 [No Abstract] [Full Text] [Related]
9. Adenylic therapy and vascular disease; a preliminary report on the administration of muscle adenylic acid in vascular disease with special attention to the post-thrombotic and post-phlebitic syndromes of the lower extremities. O'BRIEN FL; TOSI GA; BRUNELLE AR J Natl Assoc Chirop; 1956 Jun; 46(6):376-82. PubMed ID: 13320110 [No Abstract] [Full Text] [Related]
10. Inter-society consensus for the management of peripheral arterial disease. Norgren L; Hiatt WR; Dormandy JA; Nehler MR; Harris KA; Fowkes FG; Rutherford RB; Int Angiol; 2007 Jun; 26(2):81-157. PubMed ID: 17489079 [No Abstract] [Full Text] [Related]
11. Endothelial progenitor cells in 2006--where are we now? Kiernan TJ; Boilson B Cardiovasc Pathol; 2006; 15(4):236-9. PubMed ID: 16844558 [No Abstract] [Full Text] [Related]
12. [Action of embran on circulatory disorders of a secondary character]. FRUHMANN E; PERGER F Wien Med Wochenschr; 1956 Jul; 106(30):658-60. PubMed ID: 13361255 [No Abstract] [Full Text] [Related]
13. [Clinical use of Inplacen in circulatory disorders]. HILLER E; SCHURIG E Med Welt; 1962 May; 18():1049-52. PubMed ID: 13907437 [No Abstract] [Full Text] [Related]
14. Peripheral arterial disease: a high risk - but neglected - disease population. Tomson J; Lip GY BMC Cardiovasc Disord; 2005 Jun; 5(1):15. PubMed ID: 15972103 [TBL] [Abstract][Full Text] [Related]
16. [Physical treatment of peripheral vascular diseases; mechanical circulatory regulation by syncardon; study of 329 cases]. KONIGER M Gaz Med Fr; 1957 Jul; 64(13):1314-9. PubMed ID: 13462087 [No Abstract] [Full Text] [Related]
17. [The value of connective tissue massage and suction-pressure treatment in peripheral circulatory disorders]. EGERER H Med Klin; 1954 Jul; 49(30):1179-82. PubMed ID: 13202962 [No Abstract] [Full Text] [Related]